
FC Capital
Asia, Shanghai, China, Shanghai'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Fengchuan Capital is a private equity investment firm focused on the complete medical and pharmaceutical industry chain.
Investor Profile
FC Capital has backed more than 7 startups, with 2 new investments in the last 12 months alone. The firm has led 3 rounds, about 43% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in China, United States, Switzerland.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Led 1 rounds in the past year.
Stage Focus
- Series A (57%)
- Series B (29%)
- Series C (14%)
Country Focus
- China (43%)
- United States (29%)
- Switzerland (29%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Biopharma
- Therapeutics
- Pharmaceutical
- Oncology
- Business Development
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.